0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Live-type Poultry Vaccine Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-10C11575
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Live type Poultry Vaccine Market Research Report 2022
BUY CHAPTERS

Global Live-type Poultry Vaccine Market Research Report 2025

Code: QYRE-Auto-10C11575
Report
January 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Live-type Poultry Vaccine Market Size

The global market for Live-type Poultry Vaccine was valued at US$ 966 million in the year 2024 and is projected to reach a revised size of US$ 1292 million by 2031, growing at a CAGR of 4.3% during the forecast period.

Live-type Poultry Vaccine Market

Live-type Poultry Vaccine Market

A live-type poultry vaccine contains a virus or bacteria that must infect the chicken and multiply in its body to produce immunity, preferably with minimal reaction. Multiplication of the virus in the chicken is necessary, as only relatively small amounts of virus are administered to the bird.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 590%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Live-type Poultry Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live-type Poultry Vaccine.
The Live-type Poultry Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Live-type Poultry Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Live-type Poultry Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Live-type Poultry Vaccine Market Report

Report Metric Details
Report Name Live-type Poultry Vaccine Market
Accounted market size in year US$ 966 million
Forecasted market size in 2031 US$ 1292 million
CAGR 4.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Chicken
  • Other Poultry
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company MERCK, Boehringer Ingelheim, ELANCO, QYH BIOTECH, CEVA, ZOETIS, Vaxxinova, PULIKE, PHIBRO ANIMAL HEALTH CORPORATION, JINYU BIOTECHNOLOGY, HARBIN PHARMACEUTICAL GROUP, MEVAC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Live-type Poultry Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Live-type Poultry Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Live-type Poultry Vaccine Market growing?

Ans: The Live-type Poultry Vaccine Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the Live-type Poultry Vaccine Market size in 2031?

Ans: The Live-type Poultry Vaccine Market size in 2031 will be US$ 1292 million.

What is the Live-type Poultry Vaccine Market share by region?

Ans: According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Live-type Poultry Vaccine Market report?

Ans: The main players in the Live-type Poultry Vaccine Market are MERCK, Boehringer Ingelheim, ELANCO, QYH BIOTECH, CEVA, ZOETIS, Vaxxinova, PULIKE, PHIBRO ANIMAL HEALTH CORPORATION, JINYU BIOTECHNOLOGY, HARBIN PHARMACEUTICAL GROUP, MEVAC

What are the Application segmentation covered in the Live-type Poultry Vaccine Market report?

Ans: The Applications covered in the Live-type Poultry Vaccine Market report are Chicken, Other Poultry

What are the Type segmentation covered in the Live-type Poultry Vaccine Market report?

Ans: The Types covered in the Live-type Poultry Vaccine Market report are Newcastle Disease Vaccine, Infectious Bronchitis Vaccine, Fowl Pox Vaccine, Marek’s Disease Vaccine, Fowl Typhoid Vaccine, Live Coccidiosis Vaccine, Other

Recommended Reports

Poultry Equipment

Poultry Feed

Pet Nutrition

1 Live-type Poultry Vaccine Market Overview
1.1 Product Definition
1.2 Live-type Poultry Vaccine by Type
1.2.1 Global Live-type Poultry Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Newcastle Disease Vaccine
1.2.3 Infectious Bronchitis Vaccine
1.2.4 Fowl Pox Vaccine
1.2.5 Marek’s Disease Vaccine
1.2.6 Fowl Typhoid Vaccine
1.2.7 Live Coccidiosis Vaccine
1.2.8 Other
1.3 Live-type Poultry Vaccine by Application
1.3.1 Global Live-type Poultry Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Chicken
1.3.3 Other Poultry
1.4 Global Live-type Poultry Vaccine Market Size Estimates and Forecasts
1.4.1 Global Live-type Poultry Vaccine Revenue 2020-2031
1.4.2 Global Live-type Poultry Vaccine Sales 2020-2031
1.4.3 Global Live-type Poultry Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Live-type Poultry Vaccine Market Competition by Manufacturers
2.1 Global Live-type Poultry Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Live-type Poultry Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Live-type Poultry Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Live-type Poultry Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Live-type Poultry Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Live-type Poultry Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Live-type Poultry Vaccine, Date of Enter into This Industry
2.8 Global Live-type Poultry Vaccine Market Competitive Situation and Trends
2.8.1 Global Live-type Poultry Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Live-type Poultry Vaccine Players Market Share by Revenue
2.8.3 Global Live-type Poultry Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Live-type Poultry Vaccine Market Scenario by Region
3.1 Global Live-type Poultry Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Live-type Poultry Vaccine Sales by Region: 2020-2031
3.2.1 Global Live-type Poultry Vaccine Sales by Region: 2020-2025
3.2.2 Global Live-type Poultry Vaccine Sales by Region: 2026-2031
3.3 Global Live-type Poultry Vaccine Revenue by Region: 2020-2031
3.3.1 Global Live-type Poultry Vaccine Revenue by Region: 2020-2025
3.3.2 Global Live-type Poultry Vaccine Revenue by Region: 2026-2031
3.4 North America Live-type Poultry Vaccine Market Facts & Figures by Country
3.4.1 North America Live-type Poultry Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Live-type Poultry Vaccine Sales by Country (2020-2031)
3.4.3 North America Live-type Poultry Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Live-type Poultry Vaccine Market Facts & Figures by Country
3.5.1 Europe Live-type Poultry Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Live-type Poultry Vaccine Sales by Country (2020-2031)
3.5.3 Europe Live-type Poultry Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Live-type Poultry Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Live-type Poultry Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Live-type Poultry Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Live-type Poultry Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Live-type Poultry Vaccine Market Facts & Figures by Country
3.7.1 Latin America Live-type Poultry Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Live-type Poultry Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Live-type Poultry Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Live-type Poultry Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Live-type Poultry Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Live-type Poultry Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Live-type Poultry Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Live-type Poultry Vaccine Sales by Type (2020-2031)
4.1.1 Global Live-type Poultry Vaccine Sales by Type (2020-2025)
4.1.2 Global Live-type Poultry Vaccine Sales by Type (2026-2031)
4.1.3 Global Live-type Poultry Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Live-type Poultry Vaccine Revenue by Type (2020-2031)
4.2.1 Global Live-type Poultry Vaccine Revenue by Type (2020-2025)
4.2.2 Global Live-type Poultry Vaccine Revenue by Type (2026-2031)
4.2.3 Global Live-type Poultry Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Live-type Poultry Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Live-type Poultry Vaccine Sales by Application (2020-2031)
5.1.1 Global Live-type Poultry Vaccine Sales by Application (2020-2025)
5.1.2 Global Live-type Poultry Vaccine Sales by Application (2026-2031)
5.1.3 Global Live-type Poultry Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Live-type Poultry Vaccine Revenue by Application (2020-2031)
5.2.1 Global Live-type Poultry Vaccine Revenue by Application (2020-2025)
5.2.2 Global Live-type Poultry Vaccine Revenue by Application (2026-2031)
5.2.3 Global Live-type Poultry Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Live-type Poultry Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 MERCK
6.1.1 MERCK Company Information
6.1.2 MERCK Description and Business Overview
6.1.3 MERCK Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 MERCK Live-type Poultry Vaccine Product Portfolio
6.1.5 MERCK Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Company Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boehringer Ingelheim Live-type Poultry Vaccine Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 ELANCO
6.3.1 ELANCO Company Information
6.3.2 ELANCO Description and Business Overview
6.3.3 ELANCO Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 ELANCO Live-type Poultry Vaccine Product Portfolio
6.3.5 ELANCO Recent Developments/Updates
6.4 QYH BIOTECH
6.4.1 QYH BIOTECH Company Information
6.4.2 QYH BIOTECH Description and Business Overview
6.4.3 QYH BIOTECH Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 QYH BIOTECH Live-type Poultry Vaccine Product Portfolio
6.4.5 QYH BIOTECH Recent Developments/Updates
6.5 CEVA
6.5.1 CEVA Company Information
6.5.2 CEVA Description and Business Overview
6.5.3 CEVA Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CEVA Live-type Poultry Vaccine Product Portfolio
6.5.5 CEVA Recent Developments/Updates
6.6 ZOETIS
6.6.1 ZOETIS Company Information
6.6.2 ZOETIS Description and Business Overview
6.6.3 ZOETIS Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 ZOETIS Live-type Poultry Vaccine Product Portfolio
6.6.5 ZOETIS Recent Developments/Updates
6.7 Vaxxinova
6.7.1 Vaxxinova Company Information
6.7.2 Vaxxinova Description and Business Overview
6.7.3 Vaxxinova Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Vaxxinova Live-type Poultry Vaccine Product Portfolio
6.7.5 Vaxxinova Recent Developments/Updates
6.8 PULIKE
6.8.1 PULIKE Company Information
6.8.2 PULIKE Description and Business Overview
6.8.3 PULIKE Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 PULIKE Live-type Poultry Vaccine Product Portfolio
6.8.5 PULIKE Recent Developments/Updates
6.9 PHIBRO ANIMAL HEALTH CORPORATION
6.9.1 PHIBRO ANIMAL HEALTH CORPORATION Company Information
6.9.2 PHIBRO ANIMAL HEALTH CORPORATION Description and Business Overview
6.9.3 PHIBRO ANIMAL HEALTH CORPORATION Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 PHIBRO ANIMAL HEALTH CORPORATION Live-type Poultry Vaccine Product Portfolio
6.9.5 PHIBRO ANIMAL HEALTH CORPORATION Recent Developments/Updates
6.10 JINYU BIOTECHNOLOGY
6.10.1 JINYU BIOTECHNOLOGY Company Information
6.10.2 JINYU BIOTECHNOLOGY Description and Business Overview
6.10.3 JINYU BIOTECHNOLOGY Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 JINYU BIOTECHNOLOGY Live-type Poultry Vaccine Product Portfolio
6.10.5 JINYU BIOTECHNOLOGY Recent Developments/Updates
6.11 HARBIN PHARMACEUTICAL GROUP
6.11.1 HARBIN PHARMACEUTICAL GROUP Company Information
6.11.2 HARBIN PHARMACEUTICAL GROUP Description and Business Overview
6.11.3 HARBIN PHARMACEUTICAL GROUP Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 HARBIN PHARMACEUTICAL GROUP Live-type Poultry Vaccine Product Portfolio
6.11.5 HARBIN PHARMACEUTICAL GROUP Recent Developments/Updates
6.12 MEVAC
6.12.1 MEVAC Company Information
6.12.2 MEVAC Description and Business Overview
6.12.3 MEVAC Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 MEVAC Live-type Poultry Vaccine Product Portfolio
6.12.5 MEVAC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Live-type Poultry Vaccine Industry Chain Analysis
7.2 Live-type Poultry Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Live-type Poultry Vaccine Production Mode & Process Analysis
7.4 Live-type Poultry Vaccine Sales and Marketing
7.4.1 Live-type Poultry Vaccine Sales Channels
7.4.2 Live-type Poultry Vaccine Distributors
7.5 Live-type Poultry Vaccine Customer Analysis
8 Live-type Poultry Vaccine Market Dynamics
8.1 Live-type Poultry Vaccine Industry Trends
8.2 Live-type Poultry Vaccine Market Drivers
8.3 Live-type Poultry Vaccine Market Challenges
8.4 Live-type Poultry Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Live-type Poultry Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Live-type Poultry Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Live-type Poultry Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Live-type Poultry Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Live-type Poultry Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Live-type Poultry Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Live-type Poultry Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Live-type Poultry Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Live-type Poultry Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Live-type Poultry Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Live-type Poultry Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Live-type Poultry Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Live-type Poultry Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live-type Poultry Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Live-type Poultry Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Live-type Poultry Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Live-type Poultry Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Live-type Poultry Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Live-type Poultry Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Live-type Poultry Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Live-type Poultry Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Live-type Poultry Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Live-type Poultry Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Live-type Poultry Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Live-type Poultry Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Live-type Poultry Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Live-type Poultry Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Live-type Poultry Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Live-type Poultry Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Live-type Poultry Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Live-type Poultry Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Live-type Poultry Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Live-type Poultry Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Live-type Poultry Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Live-type Poultry Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Live-type Poultry Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Live-type Poultry Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Live-type Poultry Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Live-type Poultry Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Live-type Poultry Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Live-type Poultry Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Live-type Poultry Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Live-type Poultry Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Live-type Poultry Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Live-type Poultry Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Live-type Poultry Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Live-type Poultry Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Live-type Poultry Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Live-type Poultry Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Live-type Poultry Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Live-type Poultry Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Live-type Poultry Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Live-type Poultry Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Live-type Poultry Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Live-type Poultry Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Live-type Poultry Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Live-type Poultry Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Live-type Poultry Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Live-type Poultry Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Live-type Poultry Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Live-type Poultry Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Live-type Poultry Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Live-type Poultry Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Live-type Poultry Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Live-type Poultry Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Live-type Poultry Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Live-type Poultry Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Live-type Poultry Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. MERCK Company Information
 Table 71. MERCK Description and Business Overview
 Table 72. MERCK Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. MERCK Live-type Poultry Vaccine Product
 Table 74. MERCK Recent Developments/Updates
 Table 75. Boehringer Ingelheim Company Information
 Table 76. Boehringer Ingelheim Description and Business Overview
 Table 77. Boehringer Ingelheim Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Boehringer Ingelheim Live-type Poultry Vaccine Product
 Table 79. Boehringer Ingelheim Recent Developments/Updates
 Table 80. ELANCO Company Information
 Table 81. ELANCO Description and Business Overview
 Table 82. ELANCO Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. ELANCO Live-type Poultry Vaccine Product
 Table 84. ELANCO Recent Developments/Updates
 Table 85. QYH BIOTECH Company Information
 Table 86. QYH BIOTECH Description and Business Overview
 Table 87. QYH BIOTECH Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. QYH BIOTECH Live-type Poultry Vaccine Product
 Table 89. QYH BIOTECH Recent Developments/Updates
 Table 90. CEVA Company Information
 Table 91. CEVA Description and Business Overview
 Table 92. CEVA Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. CEVA Live-type Poultry Vaccine Product
 Table 94. CEVA Recent Developments/Updates
 Table 95. ZOETIS Company Information
 Table 96. ZOETIS Description and Business Overview
 Table 97. ZOETIS Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. ZOETIS Live-type Poultry Vaccine Product
 Table 99. ZOETIS Recent Developments/Updates
 Table 100. Vaxxinova Company Information
 Table 101. Vaxxinova Description and Business Overview
 Table 102. Vaxxinova Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Vaxxinova Live-type Poultry Vaccine Product
 Table 104. Vaxxinova Recent Developments/Updates
 Table 105. PULIKE Company Information
 Table 106. PULIKE Description and Business Overview
 Table 107. PULIKE Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. PULIKE Live-type Poultry Vaccine Product
 Table 109. PULIKE Recent Developments/Updates
 Table 110. PHIBRO ANIMAL HEALTH CORPORATION Company Information
 Table 111. PHIBRO ANIMAL HEALTH CORPORATION Description and Business Overview
 Table 112. PHIBRO ANIMAL HEALTH CORPORATION Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. PHIBRO ANIMAL HEALTH CORPORATION Live-type Poultry Vaccine Product
 Table 114. PHIBRO ANIMAL HEALTH CORPORATION Recent Developments/Updates
 Table 115. JINYU BIOTECHNOLOGY Company Information
 Table 116. JINYU BIOTECHNOLOGY Description and Business Overview
 Table 117. JINYU BIOTECHNOLOGY Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. JINYU BIOTECHNOLOGY Live-type Poultry Vaccine Product
 Table 119. JINYU BIOTECHNOLOGY Recent Developments/Updates
 Table 120. HARBIN PHARMACEUTICAL GROUP Company Information
 Table 121. HARBIN PHARMACEUTICAL GROUP Description and Business Overview
 Table 122. HARBIN PHARMACEUTICAL GROUP Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. HARBIN PHARMACEUTICAL GROUP Live-type Poultry Vaccine Product
 Table 124. HARBIN PHARMACEUTICAL GROUP Recent Developments/Updates
 Table 125. MEVAC Company Information
 Table 126. MEVAC Description and Business Overview
 Table 127. MEVAC Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. MEVAC Live-type Poultry Vaccine Product
 Table 129. MEVAC Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Live-type Poultry Vaccine Distributors List
 Table 133. Live-type Poultry Vaccine Customers List
 Table 134. Live-type Poultry Vaccine Market Trends
 Table 135. Live-type Poultry Vaccine Market Drivers
 Table 136. Live-type Poultry Vaccine Market Challenges
 Table 137. Live-type Poultry Vaccine Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Live-type Poultry Vaccine
 Figure 2. Global Live-type Poultry Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Live-type Poultry Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Newcastle Disease Vaccine Product Picture
 Figure 5. Infectious Bronchitis Vaccine Product Picture
 Figure 6. Fowl Pox Vaccine Product Picture
 Figure 7. Marek’s Disease Vaccine Product Picture
 Figure 8. Fowl Typhoid Vaccine Product Picture
 Figure 9. Live Coccidiosis Vaccine Product Picture
 Figure 10. Other Product Picture
 Figure 11. Global Live-type Poultry Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 12. Global Live-type Poultry Vaccine Market Share by Application: 2024 & 2031
 Figure 13. Chicken
 Figure 14. Other Poultry
 Figure 15. Global Live-type Poultry Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Live-type Poultry Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Live-type Poultry Vaccine Sales (2020-2031) & (K Units)
 Figure 18. Global Live-type Poultry Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 19. Live-type Poultry Vaccine Report Years Considered
 Figure 20. Live-type Poultry Vaccine Sales Share by Manufacturers in 2024
 Figure 21. Global Live-type Poultry Vaccine Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Live-type Poultry Vaccine Players: Market Share by Revenue in Live-type Poultry Vaccine in 2024
 Figure 23. Live-type Poultry Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Live-type Poultry Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Live-type Poultry Vaccine Sales Market Share by Country (2020-2031)
 Figure 26. North America Live-type Poultry Vaccine Revenue Market Share by Country (2020-2031)
 Figure 27. United States Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Live-type Poultry Vaccine Sales Market Share by Country (2020-2031)
 Figure 30. Europe Live-type Poultry Vaccine Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Live-type Poultry Vaccine Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Live-type Poultry Vaccine Revenue Market Share by Region (2020-2031)
 Figure 38. China Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Live-type Poultry Vaccine Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Live-type Poultry Vaccine Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Live-type Poultry Vaccine Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Live-type Poultry Vaccine Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Live-type Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Live-type Poultry Vaccine by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Live-type Poultry Vaccine by Type (2020-2031)
 Figure 59. Global Live-type Poultry Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Live-type Poultry Vaccine by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Live-type Poultry Vaccine by Application (2020-2031)
 Figure 62. Global Live-type Poultry Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 63. Live-type Poultry Vaccine Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension